Humana (HUM) PT Lowered to $327 at Barclays
Barclays analyst Steven Valiquette lowered the price target on Humana (NYSE: HUM) to $327.00 (from $351.00) while maintaining a Overweight rating.
Barclays analyst Steven Valiquette lowered the price target on Humana (NYSE: HUM) to $327.00 (from $351.00) while maintaining a Overweight rating.